Table 2. Age-specific results of HPV genotyping by HPV carcinogenicity categories among women positive in HPV screening.
|
PCR test |
HPV classificationa |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| |
Total |
Negative |
Any HPV |
Group 1/2Ab |
Group 2Bc |
Group 3d |
|||||
| Age group (y) | n | n | % of HC2+ | n | % of HC2+ | n | % of HC2+ | n | % of HC2+ | n | % of HC2+ |
| 25 |
417 |
105 |
25.2 |
312 |
74.8 |
273 |
65.3 |
27 |
6.5 |
12 |
2.9 |
| 30 |
550 |
136 |
24.7 |
414 |
75.3 |
361 |
65.5 |
44 |
8.0 |
9 |
1.6 |
| 35 |
369 |
104 |
28.1 |
265 |
71.8 |
220 |
59.3 |
37 |
10.0 |
8 |
2.2 |
| 40 |
302 |
66 |
21.9 |
236 |
78.1 |
190 |
62.7 |
42 |
13.9 |
4 |
1.3 |
| 45 |
223 |
84 |
37.7 |
139 |
62.3 |
106 |
47.3 |
31 |
13.8 |
2 |
0.9 |
| 50 |
233 |
76 |
32.6 |
157 |
67.4 |
118 |
50.4 |
32 |
13.7 |
7 |
3.0 |
| 55 |
256 |
104 |
40.6 |
152 |
59.4 |
109 |
42.4 |
28 |
10.9 |
15 |
5.9 |
| 60 |
190 |
80 |
42.1 |
110 |
57.9 |
80 |
41.5 |
21 |
10.9 |
9 |
4.7 |
| 65 |
34 |
18 |
52.9 |
16 |
47.1 |
14 |
41.2 |
2 |
5.9 |
0 |
− |
| Total | 2 574 | 773 | 30.0 | 1 801 | 70.0 | 1 471 | 57.1 | 264 | 10.3 | 66 | 2.6 |
a
On the basis of the classification of carcinogens to humans by the International Agency for Research on Cancer (IARC), Group 2B including HPV 73 in the current study.
b
Infection with one ore more Group1/2A type (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68), coinfection with HPV types of Group 2B and / or Group 3 allowed.
c
Infection with one or more Group 2B HPV type (26, 30, 53, 66, 67, 69, 70, 73 and 82), coinfection with HPV types of Group 3 allowed.
d
Infection with one or more Group 3 HPV type (6, 7, 9, 11, 40, 42, 43, 61, 74, 81, 83, 86, 87, 89, 90, 91 and 114).